Partner Content Partner Content 2018 Agenda Released: World CNS Summit Targeting Neurodegenerative Diseases
News Acorda shares crash after deaths in Parkinson's trials This could be the end for tozadenant in Parkinson's disease.
News Copaxone first on FDA's list for faster complex generic appr... Teva will attempt to block generic launch in courts
Views & Analysis Neurotechnology for tailored patient care Advanced implantable medical devices could treat hundreds of chronic conditions in the future.
News ADARx, Trex, and Retension take aim at IPOs The appetite among biotechs for IPOs shows no signs of being satisfied, with three more – ADARx, TRex, and Retension – making their intentions known.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
